The prevalence of the metabolic syndrome and its impact on the left ventricular systolic function in the patients with non-diabetic first ST elevation myocardial infarction

European Review for Medical and Pharmacological Sciences

Volumn 16, Issue 1, 2012, Pages 90-95

  Yazici, H U ^a   Poyraz, F ^a   Turfan, M ^a   Sen, N ^a   Tavil, Y ^a   Tulmac M ^a   Vatankulu, M A ^a,b   Aygul N ^a,b   Ozdogru I ^a,c   Abaci, A ^a  

^a GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^b SELCUK UNIVERSITY   (Turkey)

^c ERCIYES UNIVERSITY   (Turkey)

Author keywords

Acute myocardial infarction; Left ventricular systolic function; Metabolic syndrome

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; CARDIOVASCULAR PARAMETERS; FEMALE; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PROSPECTIVE STUDY; REVIEW; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TISSUE DOPPLER IMAGING; WALL MOTION SCORE INDEX;

AGED; AGED, 80 AND OVER; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; LIPIDS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MYOCARDIAL INFARCTION; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 84859822389     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. EXPERT PANEL ON DETECTION, EVALUATION AND TREATMENT OF HIGH BLOOD CHOLESTEROL IN ADULTS. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497.
2. TENERZ A, NORHAMMAR A, SILVEIRA A, HAMSTEN A, NILSSON G, RYDEN L, MALMBERG K. Diabetes, insulin resistance, and the metabolic syndrome in patients with acute myocardial infarction without previously known diabetes. Diabetes Care 2003;26:2770-2776. (Pubitemid 37205545)
3. ZELLER M, STEG PG, RAVISY J, LAURENT Y, JANIN-MANIFICAT L, L'HUILLIER I, BEER JC, OUDOT A, RIOUFOL G, MAKKI H, FARNIER M, ROCHETTE L, VERGES B, COTTIN Y, OBSERVATOIRE DES INFARCTUS DE COTE-D'OR SURVEY WORKING GROUP. Prevalence and impact of metabolic syndrome on hospital outcomes in acute myocardial infarction. Arch Intern Med 2005;165:1192-1198. (Pubitemid 40720745)
4. MALIK S, WONG ND, FRANKLIN SS, KAMATH T V, L'ITALIEN GJ, PIO JR, WILLIAMS GR. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 2004;110:1245-1250. (Pubitemid 39202340)
5. GRUNDY SM, CLEEMAN JI, DANIELS SR, DONATO KA, ECKEL RH, FRANKLIN BA, GORDON DJ, KRAUSS RM, SAVAGE PJ, SMITH SC JR, SPERTUS JA, COSTA F. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 2005;112:2735-2752. (Pubitemid 41532612)
6. ISOMAA B, ALMGREN P, TUOMI T, FORSEN B, LAHTI K, NISSEN M, TASKINEN MR, GROOP L. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001;24:683-689. (Pubitemid 32893993)
7. WONG C Y, O'MOORE-SULLIVAN T, FANG ZY, HALUSKA B, LEANO R, MARWICK TH. Myocardial and vascular dysfunction and exercise capacity in the metabolic syndrome. Am J Cardiol 2005;96:1686-1691. (Pubitemid 41790392)
8. OBEIDAT O, ALAM M, DIVINE GW, KHAJA F, GOLDSTEIN S, SABBAH H. Echocardiographic predictors of prognosis after first acute myocardial infarction. Am J Cardiol 2004;94:1278-1280. (Pubitemid 39469948)
9. ST JOHN SUTTON M, PFEFFER MA, PLAPPERT T, ROULEAU JL, MOYE LA, DAGENAIS GR, LAMAS GA, KLEIN M, SUSSEX B, GOLDMAN S. Acute myocardial infarction antiplatelet and thrombolytic treatment: quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction: the protective effects of captopril. Circulation 1994;89:68-75. (Pubitemid 24026473)
10. NIEUWDORP M, STROES ESG, MEIJERS JCM, BÜLLER H. Hypercoagulability in the metabolic syndrome. Curr Opin Pharmacol 2005;5:155-159. (Pubitemid 40378746)
11. THE JOINT EUROPEAN SOCIETY OF CARDIOLOGY/AMERICAN COLLEGE OF CARDIOLOGY COMMITTEE. Myocardial infarction redefined-a consensus document of the joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000;36:959-969.
12. GORCSAN J, GULATI VK, MANDARINO WA, KATZ WE. Color-coded measures of myocardial velocity throughout the cardiac cycle by tissue Doppler imaging to quantify regional left ventricular function. Am Heart J 1996;131:1203-1213. (Pubitemid 26177001)
13. YU CM, LIN H, HO PC, YANG H. Assessment of left and right ventricular systolic and diastolic synchronicity in normal subjects by tissue Doppler echocardiography and the effects of age and heart rate. Echocardiography 2003;20:19-27. (Pubitemid 36351142)
14. ALAM M, WARDELL J, ANDERSSON E, SAMAD BA, NORDLANDER R. Effects of first myocardial infarction on left ventricular systolic and diastolic function with the use of mitral annular velocity determined by pulsed wave Doppler tissue imaging. J Am Soc Echocardiogr 2000;13:343-352. (Pubitemid 30322432)
15. SANDERSON JE. Heart failure with a normal ejection fraction. Heart 2007;93:155-158.
16. ALAM M, WITT N, NORDLANDER R, SAMAD AB. Detection of abnormal left ventricular function by Doppler tissue imaging in patients with a first myocardial infarction and showing normal function assessed by conventional echocardiography. Eur J Echocardiography 2007;8:37-41. (Pubitemid 46112109)
17. NAGUEH S F, BACHINSKI LL, MEYER D, HILL R, ZOGHBI WA, TAM JW, QUIÑONES MA, ROBERTS R, MARIAN AJ. Tissue Doppler imaging consistently detects myocardial abnormalities in patients with hypertrophic cardiomyopathy and provides a novel means for an early diagnosis before and independently of hypertrophy. Circulation 2001;104:128-130. (Pubitemid 32655824)
18. AGRICOLA E, GALDERISI M, OPPIZZI M, SCHINKEL A F, MAISANO F, DE BONIS M, MARGONATO A, MASERI A, ALFIERI O. Pulsed tissue Doppler imaging detects early myocardial dysfunction in asymptomatic patients with severe mitral regurgitation. Heart 2004;90:406-410. (Pubitemid 38406915)
19. YASAR AS, BILEN E, BILGE M, ARSLANTAS U, KARAKAS F. Impact of metabolic syndrome on coronary patency after thrombolytic therapy for acute myocardial infarction. Coronary Artery Dis 2009;20:387-391.
20. GRANDI AM, MARESCA AM, GIUDICI E, LAURITA E, MARCHESI C, SOLBIATI F, NICOLINI E, GUASTI L, VENCO A. Metabolic syndrome and morphofunctional characteristics of the left ventricle in clinically hypertensive nondiabetic subjects. Am J Hypertens 2006;19:199-205. (Pubitemid 43350174)
21. GONG H P, TAN HW, FANG NN, SONG T, LI SH, ZHONG M, ZHANG W, ZHANG Y. Impaired left ventricular systolic and diastolic function in patients with metabolic syndrome as assessed by strain and strain rate imaging. Diabetes Res Clin Pract 2009;83:300-307.
22. YANG L, WU W, ZHANG XL. Quantification of regional left ventricular systolic dysfunction in patients with coronary artery disease by pulsed Doppler tissue imaging. Eur Rev Med Pharmacol Sci 2006;10:217-222. (Pubitemid 44932331)
23. The Effects of Tissue Plasminogen Activator, Streptokinase, or Both on Coronary-Artery Patency, Ventricular Function, and Survival After Acute Myocardial Infarction. The GUSTO Angiographic Investigators. The GUSTO Angiographic Investigators. N Engl J Med 1993;329:1615-1622.
24. SCIAGRA R, SESTINI S, BOLOGNESE L, CERISANO G, BUONAMICI P, PUPI A. Comparison of dobutamine echocardiography and 99mTc-sestamibi tomography for prediction of left ventricular ejection fraction outcome after acute myocardial infarction treated with successful primary coronary angioplasty. J Nucl Med 2002;43:8-14. (Pubitemid 34101181)
25. ALPERT MA. Obesity cardiomyopathy: pathophysiology and evolution of the clinical syndrome. Am J Med Sci 2001;321:225-236. (Pubitemid 32275931)
26. HARA-NAKAMURA N, KOHARA K, SUMIMOTO T, LIN M, HIWADA K. Glucose intolerance exaggerates left ventricular hypertrophy and dysfunction in essential hypertension. Am J Hypertens 1994;7:1110-1114.
27. NORHAMMAR A, TENERZ A, NILSSON G, HAMSTEN A, EFENDÍC S, RYDÉN L, MALMBERG K. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet 2002;359:2140-2144. (Pubitemid 34694020)
28. AHNVE S, ANGELIN B, EDHAG O, BERGLUND L. Early determination of serum lipids and apolipoproteins in acute myocardial infarction: possibility for immediate intervention. J Intern Med 1989;226:297-301. (Pubitemid 19269631)
29. HENKIN Y, CRYSTAL E, GOLDBERG Y, FRIGER M, LORBER J, ZUILI I, SHANY S. Usefulness of lipoprotein changes during acute coronary syndromes for predicting post discharge lipoprotein levels. Am J Cardiol 2002;89:7-11. (Pubitemid 34066578)